
News|Slideshows|February 21, 2019
Diabetes Drugs and Cardioprotection: 8 Questions on Key Trials
Author(s)Grace Halsey
Find out what you know about which diabetes drugs in which classes show CV protective properties and results of the trials that support their use.
Advertisement
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Patient Care Online
1
Phase 3 Data Support Oral Orforglipron for Weight Maintenance After GLP-1–Based Weight Loss
2
Final Thoughts on Vasomotor Symptoms and NK Receptor Antagonism
3
Colorectal Cancer Screening in 2025: What Changed, and What Didn't, with Mark Fendrick, MD
4
Novo Nordisk Files NDA for CagriSema, Novel GLP-1-amylin Combination for Chronic Weight Management
5
















































































































































































































































































